ACASTI PHARMA INC's ticker is and the CUSIP is 00430K873. A total of 13 filers reported holding ACASTI PHARMA INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $9,662 | +15.2% | 18,418 | 0.0% | 0.00% | – |
| Q1 2023 | $8,387 | -5.3% | 18,418 | 0.0% | 0.00% | – |
| Q4 2022 | $8,856 | +342.8% | 18,418 | +458.8% | 0.00% | – |
| Q3 2022 | $2,000 | -87.5% | 3,296 | -82.1% | 0.00% | – |
| Q2 2022 | $16,000 | -27.3% | 18,418 | 0.0% | 0.00% | – |
| Q1 2022 | $22,000 | 0.0% | 18,418 | +5.5% | 0.00% | – |
| Q4 2021 | $22,000 | – | 17,456 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Virtu Financial LLC | 27,100 | $54,000 | 0.01% |
| TWO SIGMA SECURITIES, LLC | 13,370 | $27,000 | 0.00% |
| BREWIN DOLPHIN LTD | 3 | $6 | 0.00% |
| Renaissance Technologies | 43,408 | $87,000 | 0.00% |
| ROYAL BANK OF CANADA | 955 | $2,000 | 0.00% |
| JANE STREET GROUP, LLC | 18,919 | $38,000 | 0.00% |
| UBS Group AG | 4,500 | $9,000 | 0.00% |
| Sargent Bickham Lagudis LLC | 5 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 625 | $1,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |